Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas.

 Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts.

Type
Public
HQ
Billerica, US
Founded
2000
Size (employees)
640 (est)-1%
Insulet Corporation was founded in 2000 and is headquartered in Billerica, US

Insulet Corporation Office Locations

Insulet Corporation has offices in Billerica, Denver, Tulsa, Washington and in 12 other locations
Billerica, US (HQ)
200 600 Technology Park Dr

Insulet Corporation Data and Metrics

Insulet Corporation Financial Metrics

Insulet Corporation's revenue was reported to be $367 m in FY, 2016 which is a 13% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

367 m

Revenue growth (FY, 2015 - FY, 2016), %

13%

Gross profit (FY, 2016)

211.1 m

Gross profit margin (FY, 2016), %

58%

Net income (FY, 2016)

(28.9 m)

EBIT (FY, 2016)

(10.7 m)

Market capitalization (23-May-2017)

2.4 b

Closing share price (23-May-2017)

42.4

Cash (31-Dec-2016)

137.2 m

EV

2.6 b
Insulet Corporation's current market capitalization is $2.4 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

247.1 m288.7 m324.2 m367 m

Revenue growth, %

17%12%13%

Cost of goods sold

134.7 m145.4 m176.1 m155.9 m

Gross profit

112.4 m143.3 m148.2 m211.1 m

Gross profit Margin, %

45%50%46%58%

Operating expense total

141.5 m155.6 m208.9 m221.8 m

EBIT

(29.1 m)(12.3 m)(60.8 m)(10.7 m)

EBIT margin, %

(12%)(4%)(19%)(3%)

Interest expense

17.2 m14.7 m12.6 m14.4 m

Interest income

124 k129 k16.1 m

Pre tax profit

(44.9 m)(51.4 m)(73.2 m)(26.8 m)

Income tax expense

(100 k)(142 k)(291 k)(392 k)

Net Income

(45 m)(51.5 m)(73.5 m)(28.9 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

149.7 m151.2 m122.7 m137.2 m

Accounts Receivable

33.1 m39.9 m48.4 m28.8 m

Inventories

9.5 m13.1 m5.7 m7.1 m

Current Assets

198.2 m208.2 m190.8 m370 m

PP&E

32.4 m37.1 m41.8 m46.3 m

Goodwill

37.5 m37.5 m39.7 m39.7 m

Total Assets

288 m302.2 m275.1 m456.6 m

Accounts Payable

19.4 m14.7 m18.6 m13.2 m

Total Debt

116.3 m167.4 m177.2 m333 m

Current Liabilities

42.4 m44.3 m65.2 m55.7 m

Additional Paid-in Capital

651.1 m661.8 m686.2 m744.2 m

Retained Earnings

(526.5 m)(578 m)(651.5 m)(680.4 m)

Total Equity

124.6 m83.8 m34.1 m63.2 m

Debt to Equity Ratio

0.9 x2 x5.2 x5.3 x

Debt to Assets Ratio

0.4 x0.6 x0.6 x0.7 x

Financial Leverage

2.3 x3.6 x8.1 x7.2 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(45 m)(51.5 m)(73.5 m)(28.9 m)

Depreciation and Amortization

11.8 m12.2 m15.8 m13.8 m

Accounts Receivable

(4.5 m)(10 m)(9.8 m)12.6 m

Inventories

5.4 m(3.6 m)(722 k)(24 m)

Cash From Operating Activities

3.3 m8.9 m(12.6 m)15.9 m

Purchases of PP&E

(7.3 m)(11.5 m)(10.6 m)(22.1 m)

Cash From Investing Activities

(7.3 m)(11.5 m)(15.3 m)(178 m)

Cash From Financing Activities

96.4 m4 m(371 k)176.6 m

Interest Paid

5.7 m4.6 m4 m3.7 m

Income Taxes Paid

321 k124 k109 k932 k
Numbers are in $, USDY, 2016

EV/EBIT

-245.3 x

EV/CFO

165 x

Revenue/Employee

567.2 k

Debt/Equity

5.3 x

Debt/Assets

0.7 x

Financial Leverage

7.2 x

Insulet Corporation Operating Metrics

FY, 2016

Patents Issued

23

Patents Pending

32

Insulet Corporation Market Value History

Insulet Corporation Revenue Breakdown

Insulet Corporation Online and Social Media Presence

Insulet Corporation Company Life and Culture

You may also be interested in